Research suggests that slippery elm may offer some benefit for gastrointestinal and inflammatory conditions, though the direct evidence specific to IBD remains limited and preliminary. A 2002 laboratory study found that slippery elm demonstrated antioxidant activity in chemical systems and in biopsy tissue from ulcerative colitis patients, with researchers concluding it warrants further formal clinical investigation alongside several other herbs. The most clinically oriented study, a 2020 uncontrolled trial in 43 adults, reported meaningful improvements in GI symptoms and gut health markers from a multi-ingredient formula that included slippery elm among several other active ingredients, though the absence of a placebo group and small sample size make it impossible to isolate slippery elm's specific contribution or rule out placebo effects. Studies indicate that potential risks also deserve attention — a 2021 case report linked slippery elm consumption to a rare case of eosinophilic colitis, and a 2017 review on herbal use in elderly IBD patients underscores the importance of discussing any complementary remedy with a healthcare provider, particularly given the possibility of drug-herb interactions in those taking immunosuppressants or other IBD medications.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Antioxidant effects of herbal therapies used by patients with inflammatory bo... | Other | 2002 | Supports | 90 |
| Drug-Herb Interactions in the Elderly Patient with IBD: a Growing Concern. | Review | 2017 | Neutral | 75 |
| Herbal formula improves upper and lower gastrointestinal symptoms and gut hea... | RCT | 2020 | Supports | 62 |
| Subserous Type of Eosinophilic Colitis: A Rare Disease. | Other | 2021 | — | 60 |